BIO VIEW (Israel) Odds of Future Stock Price Finishing Over 0.0

BIO VIEW's future price is the expected price of BIO VIEW instrument. It is based on its current growth rate as well as the projected cash flow expected by the investors. This tool provides a mechanism to make assumptions about the upside potential and downside risk of BIO VIEW performance during a given time horizon utilizing its historical volatility.
  
Check out Trending Equities.Please specify BIO VIEW time horizon, a valid symbol (red box) and a target price (blue box) you would like BIO VIEW odds to be computed.

BIO VIEW Alerts and Suggestions

In today's market, stock alerts give investors the competitive edge they need to time the market and increase returns. Checking the ongoing alerts of BIO VIEW for significant developments is a great way to find new opportunities for your next move. Suggestions and notifications for BIO VIEW can help investors quickly react to important events or material changes in technical or fundamental conditions and significant headlines that can affect investment decisions.
BIO VIEW is not yet fully synchronised with the market data
BIO VIEW has some characteristics of a very speculative penny stock
BIO VIEW has high likelihood to experience some financial distress in the next 2 years
The company reported the revenue of 27.22 M. Net Loss for the year was (1.37 M) with profit before overhead, payroll, taxes, and interest of 14.76 M.

BIO VIEW Price Density Drivers

Market volatility will typically increase when nervous long traders begin to feel the short-sellers pressure to drive the market lower. The future price of BIO VIEW Stock often depends not only on the future outlook of the current and potential BIO VIEW's investors but also on the ongoing dynamics between investors with different trading styles. Because the market risk indicators may have small false signals, it is better to identify suitable times to hedge a portfolio using different long/short signals. BIO VIEW's indicators that are reflective of the short sentiment are summarized in the table below.
Trailing Annual Dividend Rate0.20
Float Shares10.1M
Average Daily Volume Last 10 Day12.56k
Average Daily Volume In Three Month7.62k
Trailing Annual Dividend Yield0.08%

BIO VIEW Technical Analysis

BIO VIEW's future price can be derived by breaking down and analyzing its technical indicators over time. BIO VIEW Stock technical analysis helps investors analyze different prices and returns patterns as well as diagnose historical swings to determine the real value of BIO VIEW. In general, you should focus on analyzing BIO VIEW Stock price patterns and their correlations with different microeconomic environments and drivers.

BIO VIEW Predictive Forecast Models

BIO VIEW time-series forecasting models is one of many BIO VIEW's stock analysis techniquest aimed to predict future share value based on previously observed values. Time-series forecasting models ae widely used for non-stationary data. Non-stationary data are called the data whose statistical properties e.g. the mean and standard deviation are not constant over time but instead, these metrics vary over time. These non-stationary BIO VIEW's historical data is usually called time-series. Some empirical experimentation suggests that the statistical forecasting models outperform the models based exclusively on fundamental analysis to predict the direction of the stock market movement and maximize returns from investment trading.

Things to note about BIO VIEW

Checking the ongoing alerts about BIO VIEW for important developments is a great way to find new opportunities for your next move. Our stock alerts and notifications screener for BIO VIEW help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.
BIO VIEW is not yet fully synchronised with the market data
BIO VIEW has some characteristics of a very speculative penny stock
BIO VIEW has high likelihood to experience some financial distress in the next 2 years
The company reported the revenue of 27.22 M. Net Loss for the year was (1.37 M) with profit before overhead, payroll, taxes, and interest of 14.76 M.
Check out Trending Equities. You can also try Idea Optimizer module to use advanced portfolio builder with pre-computed micro ideas to build optimal portfolio .

Other Tools for BIO VIEW Stock

When running BIO VIEW price analysis, check to measure BIO VIEW's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy BIO VIEW is operating at the current time. Most of BIO VIEW's value examination focuses on studying past and present price action to predict the probability of BIO VIEW's future price movements. You can analyze the entity against its peers and financial market as a whole to determine factors that move BIO VIEW's price. Additionally, you may evaluate how the addition of BIO VIEW to your portfolios can decrease your overall portfolio volatility.
Focused Opportunities
Build portfolios using our predefined set of ideas and optimize them against your investing preferences
Go
Balance Of Power
Check stock momentum by analyzing Balance Of Power indicator and other technical ratios
Go
Piotroski F Score
Get Piotroski F Score based on binary analysis strategy of nine different fundamentals
Go
Volatility Analysis
Get historical volatility and risk analysis based on latest market data
Go
Pair Correlation
Compare performance and examine fundamental relationship between any two equity instruments
Go
Watchlist Optimization
Optimize watchlists to build efficient portfolio or rebalance existing positions based on mean-variance optimization algorithm
Go
Theme Ratings
Determine theme ratings based on digital equity recommendations. Macroaxis theme ratings are based on combination of fundamental analysis and risk-adjusted market performance
Go
Companies Directory
Evaluate performance of over 100,000 Stocks, Funds, and ETFs against different fundamentals
Go
Equity Analysis
Research over 250,000 global equities including funds, stocks and ETFs to find investment opportunities
Go
Portfolio Manager
State of the art Portfolio Manager to monitor and improve performance of your invested capital
Go